ATXS Company Profile and Key Details

Astria Therapeutics, Inc. (NASDAQ: ATXS) stock price is $7.52 in the last trading session. During the trading session, ATXS stock reached the peak price of $7.71 while $7.33 was the lowest point it dropped to. The percentage change in ATXS stock occurred in the recent session was 1.21% while the dollar amount for the price change in ATXS stock was $0.09.

The NASDAQ listed ATXS is part of Biotechnology industry that operates in the broader Healthcare sector. Astria Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Ms. Andrea L. Matthews
Chief Bus. Officer
Mr. Andrew A. Komjathy
Chief Commercial Officer
Dr. Joanne T. Beck Ph.D.
Chief Technology Officer & Director
Mr. Benjamin S. Harshbarger J.D.
Chief Legal Officer
Mr. Noah Clauser CPA
Chief Financial Officer & Treasurer
Dr. Andrew J. Nichols Ph.D.
Chief Scientific Officer
Dr. Christopher J. Morabito M.D.
Chief Medical Officer
Ms. Keri McGrail
Senior Vice President of HR
Dr. Anthony Christopher Stevens M.D.
Interim Chief Medical Officer
Ms. Jill C. Milne Ph.D.
Co-Founder, Chief Executive Officer, Pres & Director
Mr. John Ruesch
Senior Vice President of Pharmaceutical Sciences & Technical Operations

ATXS's closing price is 5.03% higher than its 52-week low of $7.16 where as its distance from 52-week high of $16.90 is -55.5%.

Number of ATXS employees currently stands at 59.

Official Website of ATXS is: https://www.astriatx.com

ATXS could be contacted at phone 617 349 1971 and can also be accessed through its website. ATXS operates from 100 High Street, Boston, MA 02110, United States.

ATXS stock volume for the day was 244K shares. The average number of ATXS shares traded daily for last 3 months was 324.7K.

The market value of ATXS currently stands at $424.39M with its latest stock price at $7.52 and 56.43M of its shares outstanding.